According to lead researcher Dr Grigory Glenn of the biotechnology company 'Novavax', its trial has been started on 131 people from the city of Melbourne and Brisbane.
Canberra A biotechnology company in the US has announced to begin testing coronavirus drug in humans in Australia. The company has said that the medicine will be ready by the end of this year. According to lead researcher Dr Grigory Glenn of the biotechnology company 'Novavax', its trial has been started on 131 people from the city of Melbourne and Brisbane.
Glenn said in an online press conference from 'Novavax' Maryland headquarters, 'We are producing drugs and vaccines together thinking that we will be able to show that it works and is available to the public by the end of the year Will be able to get it done. Earlier, the World Health Organization (WHO) Director General Tedros Adhanom had informed the United Nations (UN) Economic and Social Council that the corona vaccine is progressing rapidly to produce a vaccine and it is estimated Will be prepared before the time. Tedross told that there are a total of 7 to 8 such teams who are very close to making this vaccine (Covid-19 Vaccine) and soon the world can get a great news.
According to Tedross, many countries have put forward a helping hand and around 100 different teams are trialing the vaccine and 8 of them are very close to it. Two months ago, we had estimated that it may take 12 to 18 months to be made, but the work has increased and it will be developed ahead of time. However, Tedross has appealed to the countries that they have raised about $ 8 billion for research and research. After the vaccine is made, a large amount of its production will also be required, so this amount is less. Tedross told that in the past he has appealed to 40 countries in this regard.
Significantly, in China, America and Europe, about a dozen experimental drugs are in the initial phase of testing or their testing is about to begin. It is not yet clear whether any of these drugs will prove to be safe and effective or not, but many medicines work in different ways and are made with different techniques. This has raised hopes that any of these drugs can be successful. 'Novavax' told the AP last month, 'We do not even touch the virus in the medicines we make, but ultimately it looks like a virus for immunity.' He said, "This is the same way that Novavax makes nanoparticle cold medicine."
 |
| Vaccine |
Glenn said in an online press conference from 'Novavax' Maryland headquarters, 'We are producing drugs and vaccines together thinking that we will be able to show that it works and is available to the public by the end of the year Will be able to get it done. Earlier, the World Health Organization (WHO) Director General Tedros Adhanom had informed the United Nations (UN) Economic and Social Council that the corona vaccine is progressing rapidly to produce a vaccine and it is estimated Will be prepared before the time. Tedross told that there are a total of 7 to 8 such teams who are very close to making this vaccine (Covid-19 Vaccine) and soon the world can get a great news.
100 teams are doing trials.
According to Tedross, many countries have put forward a helping hand and around 100 different teams are trialing the vaccine and 8 of them are very close to it. Two months ago, we had estimated that it may take 12 to 18 months to be made, but the work has increased and it will be developed ahead of time. However, Tedross has appealed to the countries that they have raised about $ 8 billion for research and research. After the vaccine is made, a large amount of its production will also be required, so this amount is less. Tedross told that in the past he has appealed to 40 countries in this regard.
Significantly, in China, America and Europe, about a dozen experimental drugs are in the initial phase of testing or their testing is about to begin. It is not yet clear whether any of these drugs will prove to be safe and effective or not, but many medicines work in different ways and are made with different techniques. This has raised hopes that any of these drugs can be successful. 'Novavax' told the AP last month, 'We do not even touch the virus in the medicines we make, but ultimately it looks like a virus for immunity.' He said, "This is the same way that Novavax makes nanoparticle cold medicine."
No comments:
Post a Comment